BOLERO-4: Phase 2 trial of first-line everolimus (EVE) plus letrozole (LET) in estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (BC)
| Affiliation auteurs | Affiliation ok |
| Titre | BOLERO-4: Phase 2 trial of first-line everolimus (EVE) plus letrozole (LET) in estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (BC) |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Royce M., Villanueva C., Ozguroglu M., Bachelot T., Azevedo S., F. Cruz M, Hegg R., Debled M., Gradishar W.J, Manlius C., Ridolfi A., Lin J., Ringeisen F., Cardoso F. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 27 |
| Date Published | OCT 1 |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1093/annonc/mdw365.1 |